ROI: Calculate your return with iXope
Australian general practices are under mounting financial pressure. That means you weigh every spending decision carefully, trying to ensure your spending choices enhance your clinical care and sustain your practice’s financial viability.
Viewed through that lens, iXope is a rare offering indeed – a compact, multifunctional tool that equips you to think beyond your current scope to improve patient care and generate new revenue.
A compact investment with a big return
iXope is a compact, handheld device that integrates:
- A dermatoscope
- An otoscope with microsuction capability
- An ophthalmoscope with an inbuilt slit lamp
- An inbuilt camera for wireless transfer to your computer.
You no longer need to purchase multiple separate devices worth over $30,000 to achieve this. With iXope, you can simply buy one compact device for $7,200.
That single investment equips you to satisfy more care needs on site, deliver lucrative in-practice procedures and make better use of your time.
A real-world scenario: the gardener with a corneal foreign body
It’s Monday morning and your first patient is Brenda. She spent the weekend gardening in windy conditions and something blew into her eye and lodged there. It wasn’t serious enough for an immediate trip to the emergency department, but it’s certainly uncomfortable and distressing.
With traditional tools, you’d identify a corneal foreign body and have no choice but to refer Brenda to the nearest eye specialist or hospital. It’s inconvenient for Brenda and it delays her care. It’s also a lost opportunity for your clinic.
With iXope’s slit-lamp capability, you can manage the issue in-house. The procedure takes minutes, Brenda leaves reassured, and your practice generates billable income. Multiply that by the number of similar presentations across a year, and the value quickly adds up.
Where the revenue comes from
With iXope, two key procedures can now stay in your practice:
- Corneal foreign body removal (MBS 42644): Medicare rebate $71.55, or private billing up to $140.
-
Microscopic ear inspection and toilet (MBS 41647): Medicare rebate $109, or private billing up to $165.
On top of this, iXope streamlines documentation, saving around 50% of the time usually spent on notes and referrals — equating to 44–128 additional billable consultations per year. That puts your practice on a firmer financial footing and improves healthcare access for your community.
Annualised ROI scenarios
Practices that use iXope for both examinations and in-practice procedures will enjoy the strongest ROI. But even those which make less use of iXope will still benefit from their investment.
With conservative usage:
- Bulk billed: 17.89% annualised ROI
- Private billing: 35.2% annualised ROI.
With optimal usage:
- Bulk billed: 44.19% annualised ROI
-
Private billing: 68.28% annualised ROI.
With optimal usage and private billing, your potential 5-year net profit could be nearly $80,000.
Breaking even in months, not years
iXope can pay for itself in as little as 5 months with optimal usage and private billing. Even with conservative assumptions, you’ve recovered your costs within about 2 years.
ROI is about more than revenue
iXope is also an investment in:
- Patient loyalty: Treating patients in-house keeps them connected to your practice so you benefit from their lifetime value.
- Work-life balance: Freeing up consultation time allows you to work through your caseload more efficiently so you can go home on time.
-
Professional reputation: Modern, digital tools position your clinic as progressive, well-equipped and able to meet the needs of your community.
Invest in growth
For a modest upfront investment, iXope gives your practice more billable procedures, more consultations, and a faster route to profitability — all while delivering better continuity of care.
In short, it’s not just a medical device; it’s a business decision that pays dividends year after year.
Disclaimer
This information is intended for healthcare professionals.
